Drug intelligence / Profile preview

TDT 064

Development stage
Unknown
Lead developer
IDEA
Modality
Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

TDT 064 is a drug-free topical gel composed of ultra-deformable phospholipid vesicles, also known as Transfersomes. It is specifically designed for the management of pain and joint stiffness associated with osteoarthritis, particularly in the knee. Unlike conventional topical treatments such as NSAIDs, TDT 064 does not contain a pharmacologically active drug substance. Instead, it utilizes a physical mechanism of action where the vesicles penetrate the skin and migrate into the synovial fluid of the joint. Once inside, these vesicles accumulate on the surfaces of the articular cartilage, acting as a bio-lubricant to reduce friction and mechanical wear. Due to this physical mode of action, TDT 064 is often regulated as a medical device (Class IIa) rather than a pharmaceutical drug in various jurisdictions.

Brand names
Flexiseq
Other names
ultra-deformable phospholipid vesiclesTransfersomessequestered phospholipid vesiclesSequentia

Beyond the preview

Go deeper on TDT 064.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TDT 064.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call